Literature DB >> 15522366

Post-traumatic endophthalmitis.

Rohan W Essex1, Qing Yi, Patrick G P Charles, Penelope J Allen.   

Abstract

OBJECTIVE: To establish risk factors for the occurrence of post-traumatic endophthalmitis, to observe the efficacy of prophylaxis, and to describe the clinical features of post-traumatic endophthalmitis.
DESIGN: Partially prospective consecutive case-control study. PARTICIPANTS: A total of 250 consecutive patients admitted to a single ophthalmic hospital with open globe injuries during a 3-year period were included.
METHODS: Patients with post-traumatic endophthalmitis were identified prospectively and added to an endophthalmitis database. All open globe injuries during the same time period were identified through a retrospective search of inpatient admissions, and their charts were reviewed. Information collected from all patient files included patient age; gender; injury setting (indoor/outdoor); wound contamination; nature of injury (site on eye, lens involvement, retained intraocular foreign body); mechanism of injury (penetration/perforation/rupture/ruptured surgical wound); prophylactic antibiotic administration, including route and timing; timing of primary repair; lensectomy at the time of primary repair; and depot corticosteroid at the time of primary repair. Any association between these parameters and the subsequent development of endophthalmitis was investigated. Any association between endophthalmitis and final visual acuity (VA) and also enucleation was evaluated. MAIN OUTCOME MEASURE: Development of endophthalmitis.
RESULTS: The frequency of endophthalmitis after open globe injury was 6.8%. The following factors were associated with the subsequent development of endophthalmitis by univariate analysis: dirty wound (14.3% vs. 4.1%, P = 0.01), retained intraocular foreign body (13.0% vs. 4.4%, P = 0.02), lens capsule breach (12.8% vs. 3.2%, P = 0.01), delayed primary repair (> or =12 hours) (11.3% vs. 2.9%, P = 0.02), and rural address (10.1% vs. 4.3%, P = 0.07). Risk factors identified after multivariate analysis were dirty injury (odds ratio [OR], 5.3; 95% confidence interval [CI)], 1.5-18.7), breach of lens capsule (OR, 4.4; 95% CI, 1.2-15.6), and delay in primary repair (per hour: OR, 1.013; 95% CI, 1.002-1.024). None of the following factors was found to be associated with post-traumatic endophthalmitis: patient age, gender, injury setting, site of injury on eye, mechanism of injury, antibiotic administration, lensectomy at the time of primary repair, and depot corticosteroid at the time of primary repair. Final VA tended to be worse in eyes with endophthalmitis (P = 0.08). Endophthalmitis did not significantly influence the frequency of enucleation/evisceration (5.9% vs. 4.3%, P = 0.55).
CONCLUSIONS: Delay in primary repair, ruptured lens capsule, and dirty wound were each independently associated with the development of post-traumatic endophthalmitis. Patients with > or =2 of these 3 risk factors had a particularly high frequency of infection.

Entities:  

Mesh:

Year:  2004        PMID: 15522366     DOI: 10.1016/j.ophtha.2003.09.041

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  72 in total

1.  Post-traumatic endophthalmitis.

Authors:  R Agrawal
Journal:  Eye (Lond)       Date:  2012-06-01       Impact factor: 3.775

Review 2.  Combined anterior and posterior segment injuries in children: a review.

Authors:  Petra Meier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-29       Impact factor: 3.117

3.  Post-traumatic endophthalmitis in 143 eyes of children and adolescents from India.

Authors:  E Rishi; P Rishi; V V Koundanya; C Sahu; R Roy; P S Bhende
Journal:  Eye (Lond)       Date:  2016-02-12       Impact factor: 3.775

4.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

5.  Pediatric open-globe injuries: clinical characteristics and factors associated with poor visual and anatomical success.

Authors:  Sabahattin Sul; Gökhan Gurelik; Safak Korkmaz; Sengül Ozdek; Berati Hasanreisoglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-05       Impact factor: 3.117

Review 6.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

7.  Poor prognostic factors in post-traumatic endophthalmitis following open globe injury.

Authors:  Sukhum Silpa-Archa; Akkaranisorn Dejkong; Kwanchanoke Kumsiang; Peranut Chotcomwongse; Janine M Preble; C Stephen Foster
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

8.  Penetrating palpebral grass awn in a dog: Unusual case of a penetrating grass awn in an eyelid.

Authors:  Andrea Marchegiani; Alessandro Fruganti; Matteo Cerquetella; Maria Paola Cassarani; Fulvio Laus; Andrea Spaterna
Journal:  J Ultrasound       Date:  2017-01-04

9.  Clinical characteristics and outcomes of fall-related open globe injuries in Japan.

Authors:  Shohei Morikawa; Yoshifumi Okamoto; Fumiki Okamoto; Naoki Inomoto; Hiroto Ishikawa; Kozo Harimoto; Tetsuo Ueda; Taiji Sakamoto; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-15       Impact factor: 3.117

10.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.